Cost-effectiveness and comparative effectiveness of biologic therapy for asthma

To evaluate relevant studies and documents that address the cost-effectiveness and comparative effectiveness of biologics current approved by the US Food and Drug Administration for the treatment of asthma.

Source: Annals of Allergy, Asthma and Immunology - January 27, 2019 Category: Allergy & Immunology Authors: William C. Anderson, Stanley J. Szefler Tags: Review Source Type: research